Kevin Donahue
Chief Executive Officer at 3X Genetics.
Earliest Form D on file: Mar 2026
Filed Mar 25, 2026
3X Genetics
Long-read tests for repeat expansion genetic disorders
Biotech, Worcester MA
Signed as Chief Executive Officer
Chief Executive Officer at 3X Genetics.
Earliest Form D on file: Mar 2026
Long-read tests for repeat expansion genetic disorders
Biotech, Worcester MA
Signed as Chief Executive Officer